~~<i id='1C018FCF49'><strike id='1C018FCF49'><tt id='1C018FCF49'><pre id='1C018FCF49'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：focus 2025-09-27 09:55:13 - browse：18943

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

focus

explore

leisure time

focus

knowledge

leisure time

AramBoghosianforSTATSANFRANCISCO—ModernaTherapeutics,themosthighlyvaluedprivatecompanyinbiotech,hasr

WSS

Weighted lottery helped low

NIH nominee Bertagnolli will get October confirmation hearing

Humana sues Biden admin over Medicare Advantage audit rule

Why Novartis is changing the name of its research labs

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Democratic lawmaker calls for 'well

hotspot

leisure time

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Stem cell treatment guidelines are released by FDA

Walensky prepares to leave CDC — and Congress — behind

The (many) problems with a new study criticizing cancer screening

Walensky prepares to leave CDC — and Congress — behind

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

Novavax promises a turnaround & Lilly roils the obesity market

Snackable artificial intelligence, expert AI, and the pharma industry

Wildfire smoke exposes gaps in outdoor worker protections

In medicine, common shorthands can shortchange care

explore

NIH nominee Bertagnolli will get October confirmation hearing

House transparency, PBM reform bill gains bipartisan support

Amazon on where the company's health care bets are headed next

What American doctors can learn from their Israeli counterparts

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

Amazon on where the company's health care bets are headed next

leisure time

focus

knowledge

leisure time